These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32898248)

  • 1. Recipient-specific T-cell repertoire reconstitution in the gut following murine hematopoietic cell transplant.
    Zheng P; Tamaresis J; Thangavelu G; Xu L; You X; Blazar BR; Negrin RS; Zehnder JL; Iliopoulou BP; Meyer EH
    Blood Adv; 2020 Sep; 4(17):4232-4243. PubMed ID: 32898248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Donor T-Cell Repertoire Profiling in Recipient Lymphoid and Parenchyma Organs Reveals GVHD Pathogenesis at Clonal Levels After Bone Marrow Transplantation in Mice.
    Wu Y; Fu J; Wang H; Yu XZ
    Front Immunol; 2021; 12():778996. PubMed ID: 34950143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of donor mice with an alpha beta T-cell receptor monoclonal antibody induces prolonged T-cell nonresponsiveness and effectively prevents lethal graft-versus-host disease in murine recipients of major histocompatibility complex (MHC)-matched and MHC-mismatched donor marrow grafts.
    Drobyski WR; Majewski D
    Blood; 1996 Jun; 87(12):5355-69. PubMed ID: 8652851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the Whole CDR3 T Cell Receptor Repertoire after Hematopoietic Stem Cell Transplantation in 2 Clinical Cohorts.
    Shah O; Tamaresis JS; Kenyon LJ; Xu L; Zheng P; Gupta P; Rangarajan K; Lee S; Spellman S; Nikiforow S; Zehnder J; Meyer EH
    Biol Blood Marrow Transplant; 2020 Jun; 26(6):1050-1070. PubMed ID: 32081787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbiota dictate T cell clonal selection to augment graft-versus-host disease after stem cell transplantation.
    Yeh AC; Koyama M; Waltner OG; Minnie SA; Boiko JR; Shabaneh TB; Takahashi S; Zhang P; Ensbey KS; Schmidt CR; Legg SRW; Sekiguchi T; Nelson E; Bhise SS; Stevens AR; Goodpaster T; Chakka S; Furlan SN; Markey KA; Bleakley ME; Elson CO; Bradley PH; Hill GR
    Immunity; 2024 Jul; 57(7):1648-1664.e9. PubMed ID: 38876098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in the T-cell receptor V beta gene repertoire after allogeneic hematopoietic stem cell transplantation.
    Liu QF; Li YQ; Yang D; Zhang Y; Yang LJ; Chen SH; Sun J; Liu XL; Zhou SY
    Chin Med J (Engl); 2004 Mar; 117(3):413-8. PubMed ID: 15043783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organ-specific T cell receptor repertoire in target organs of murine graft-versus-host after transplantation across minor histocompatibility antigen barriers.
    Schilbach K; Schick J; Fluhr H; Marquordt K; Wehrmann M; Schütt BS; Schlegel PG; Niethammer D; Eyrich M
    Transplantation; 2004 Jul; 78(1):31-40. PubMed ID: 15257036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T Cell Repertoire Evolution after Allogeneic Bone Marrow Transplantation: An Organizational Perspective.
    Meier JA; Haque M; Fawaz M; Abdeen H; Coffey D; Towlerton A; Abdeen A; Toor A; Warren E; Reed J; Kanakry CG; Keating A; Luznik L; Toor AA
    Biol Blood Marrow Transplant; 2019 May; 25(5):868-882. PubMed ID: 30677510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective elimination of alloreactive donor T cells attenuates graft-versus-host disease and enhances T-cell reconstitution.
    Gendelman M; Yassai M; Tivol E; Krueger A; Gorski J; Drobyski WR
    Biol Blood Marrow Transplant; 2003 Dec; 9(12):742-52. PubMed ID: 14677113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous superantigens in allogeneic bone marrow transplant recipients rapidly and selectively expand donor T cells which can produce IFN-gamma.
    Jones MS; Riley R; Hamilton BL; Paupe J; Perez D; Levy RB
    Bone Marrow Transplant; 1994 Nov; 14(5):725-35. PubMed ID: 7889005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reconstitution of gammadelta T cell repertoire diversity after human allogeneic hematopoietic cell transplantation and the role of peripheral expansion of mature T cell population in the graft.
    Hirokawa M; Horiuchi T; Kawabata Y; Kitabayashi A; Miura AB
    Bone Marrow Transplant; 2000 Jul; 26(2):177-85. PubMed ID: 10918428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T Cell Clonal Dynamics Determined by High-Resolution TCR-β Sequencing in Recipients after Allogeneic Hematopoietic Cell Transplantation.
    Leick M; Gittelman RM; Yusko E; Sanders C; Robins H; DeFilipp Z; Nikiforow S; Ritz J; Chen YB
    Biol Blood Marrow Transplant; 2020 Sep; 26(9):1567-1574. PubMed ID: 32417490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical T Cell Receptor Repertoire Deep Sequencing and Analysis: An Application to Monitor Immune Reconstitution Following Cord Blood Transplantation.
    Gkazi AS; Margetts BK; Attenborough T; Mhaldien L; Standing JF; Oakes T; Heather JM; Booth J; Pasquet M; Chiesa R; Veys P; Klein N; Chain B; Callard R; Adams SP
    Front Immunol; 2018; 9():2547. PubMed ID: 30455696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological MEK inhibition promotes polyclonal T-cell reconstitution and suppresses xenogeneic GVHD.
    Itamura H; Shindo T; Muranushi H; Kitaura K; Okada S; Shin-I T; Suzuki R; Takaori-Kondo A; Kimura S
    Cell Immunol; 2021 Sep; 367():104410. PubMed ID: 34274730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect on the proliferation and apoptosis of alloreactive T cells of cell dose in a murine MHC-mismatched hematopoietic cell transplantation model.
    Fujioka T; Taniguchi Y; Masuda T; Nishida S; Ikegame K; Kawakami M; Tsuboi A; Hosen N; Murakami M; Oji Y; Oka Y; Sugiyama H; Kawase I; Ogawa H
    Transpl Immunol; 2003; 11(2):187-95. PubMed ID: 12799203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of TIM-1 on the donor graft ameliorates graft-versus-host disease following hematopoietic cell transplantation.
    Iliopoulou BP; Hsu K; Pérez-Cruz M; Tang SW; Pang WW; Erkers T; Kambham N; Freeman GJ; Dekruyff RH; Meyer EH
    Blood Adv; 2019 Nov; 3(21):3419-3431. PubMed ID: 31714958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct TCRAV and TCRBV repertoire and CDR3 sequence of T lymphocytes clonally expanded in blood and GVHD lesions after human allogeneic bone marrow transplantation.
    Hirokawa M; Matsutani T; Saitoh H; Ichikawa Y; Kawabata Y; Horiuchi T; Kitabayashi A; Yoshioka T; Tsuruta Y; Suzuki R; Miura AB; Sawada K
    Bone Marrow Transplant; 2002 Dec; 30(12):915-23. PubMed ID: 12476285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanded donor natural killer cell and IL-2, IL-15 treatment efficacy in allogeneic hematopoietic stem cell transplantation.
    Chen G; Wu D; Wang Y; Cen J; Feng Y; Sun A; Tang X; Chang H; Zhu Z
    Eur J Haematol; 2008 Sep; 81(3):226-35. PubMed ID: 18573173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD425 T cells to allow an effective graft-versus-leukemia response.
    Jones SC; Murphy GF; Korngold R
    Biol Blood Marrow Transplant; 2003 Apr; 9(4):243-56. PubMed ID: 12720217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A strategy to reconstitute immunity without GVHD via adoptive allogeneic Tscm therapy.
    Guan L; Sun Y; Si Y; Yan Q; Han Z; Liu Y; Han T
    Front Immunol; 2024; 15():1367609. PubMed ID: 39035005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.